Parkinson’s disease is classically defined by the loss of dopaminergic neurons in the substantia nigra pars compacta and the accumulation of misfolded alpha-synuclein into Lewy bodies. But the clinical picture is increasingly understood as systemic. Misfolded alpha-synuclein acts as a damage-associated molecular pattern, provoking microglia, the brain’s resident immune cells, into a chronically activated, pro-inflammatory state. These activated microglia release tumor necrosis factor-alpha, interleukin-1 beta, and reactive oxygen species through pathways such as NF-kappaB, which in turn kills more neurons and further impairs the microglia’s ability to clear alpha-synuclein aggregates. The result is a self-perpetuating neurotoxic loop that current therapies, chiefly levodopa-based dopaminergic replacement, do nothing to interrupt.

The research team, led by investigators at Wenzhou Medical University, began not in the animal facility but in genetic epidemiology. Using two-sample Mendelian randomization with summary data from large genome-wide association studies, they asked whether genetically predicted serum trigonelline levels are causally linked to alpha-synuclein levels. The inverse variance weighted analysis revealed a significant protective association, with an odds ratio of 0.858, and the weighted median method corroborated the result. Sensitivity analyses found no heterogeneity among the instrumental variables, no evidence of horizontal pleiotropy, and no single genetic variant driving the signal. While Mendelian randomization is only as strong as its assumptions, the analysis provided a genetically grounded rationale for the experiments that followed.

For the in vivo work, the team used an adeno-associated virus to overexpress the A53T mutant form of alpha-synuclein in the substantia nigra of C57BL/6J mice, a model that recapitulates alpha-synucleinopathy, dopaminergic degeneration, neuroinflammation, and motor impairment. Two weeks after viral injection, mice received daily oral trigonelline at 5 milligrams per kilogram for 30 consecutive days, a dose chosen from prior mouse work confirming its efficacy and lack of toxicity. The behavioral results were striking. Trigonelline-treated mice traversed a narrow balance beam faster, stayed longer on an accelerating rotarod, and descended a vertical pole more quickly than their vehicle-treated counterparts, collectively indicating preserved motor coordination and reduced bradykinesia.

Histology and biochemistry told a consistent story beneath the behavior. Immunohistochemistry for tyrosine hydroxylase, the rate-limiting enzyme in dopamine synthesis, revealed substantial preservation of dopaminergic neurons in the substantia nigra of trigonelline-treated mice, and Western blotting confirmed that nigral tyrosine hydroxylase protein levels, which had dropped in the disease model, were significantly restored. Just as importantly, immunofluorescence staining showed that the accumulation of phosphorylated alpha-synuclein at serine 129, the pathological hallmark that drives neurotoxicity, was markedly reduced in treated animals, a finding confirmed at the protein level by Western blot. The compound, in other words, appeared to suppress the very pathology that sets the disease cascade in motion.

The mechanistic core of the study lies in inflammatory signaling. In the substantia nigra of diseased mice, microglia bearing the activation markers Iba-1 and CD11b adopted a hypertrophic, ameboid morphology, and levels of the pro-inflammatory effectors COX-2, TNF-alpha, and IL-1 beta rose sharply. Trigonelline treatment reversed all of these changes. Probing upstream, the researchers found that the disease model exhibited hyperactivation of the PI3K/AKT pathway, reflected in elevated phosphorylation ratios of PI3K and AKT, together with increased phosphorylation of the NF-kappaB p65 subunit, the master transcriptional regulator of inflammation. Trigonelline normalized all three phosphorylation events, and quantitative PCR showed corresponding suppression of Il1b, Il6, and Nfkb1 messenger RNA. The data position trigonelline as a suppressor of the AKT-to-NF-kappaB axis that governs microglial activation, a pathway increasingly recognized as a promising therapeutic target in neurodegeneration.

What elevates the study above a straightforward neuroprotection paper is its attention to the periphery. Consistent with the Braak hypothesis, which proposes that Parkinson’s pathology may originate in the enteric nervous system and propagate to the brain via the vagus nerve, the team examined the colons of their mice. Diseased animals showed mucosal atrophy, depleted goblet cells, reduced glandular depth, and fragmented tight junctions, with diminished and discontinuous staining for the barrier proteins ZO-1 and Occludin. Trigonelline restored the continuous, belt-like organization of both proteins and preserved crypt architecture. The compound also reduced the infiltration of Iba-1-positive and CD11b-positive myeloid cells in the colonic lamina propria, suppressed colonic COX-2 and TNF-alpha, and visibly reduced enteric phosphorylated alpha-synuclein, suggesting it lightens the peripheral pathological burden as well as the central one.

Colon content sequencing with 16S rRNA amplicon analysis revealed a parallel microbial transformation. Principal coordinate analysis based on Bray-Curtis distances separated the trigonelline and disease groups cleanly, with a PERMANOVA statistic of 0.7971 and a p-value of 0.001. LEfSe biomarker analysis showed that diseased mice were enriched with pro-inflammatory and opportunistic taxa, including Desulfovibrionaceae, Helicobacteraceae, and the genera Dubosiella and Desulfovibrio, while trigonelline treatment enriched beneficial families such as Erysipelotrichaceae and Clostridiaceae and genera including Ileibacterium, Bilophila, and Gordonibacter. The correlations with behavior were particularly compelling: Desulfovibrio abundance tracked positively with the time needed to complete beam and pole tests, whereas Ileibacterium, expanded by trigonelline, correlated negatively with those latencies. This matters because patient-derived Desulfovibrio strains have previously been shown to enhance alpha-synuclein aggregation in vivo, making their suppression by a dietary compound especially noteworthy.

Untargeted metabolomics of colon contents added a third layer of evidence. The analysis identified 309 differential metabolites, and Procrustes analysis demonstrated clear concordance between the metabolomic configuration and the microbial structure, indicating coordinated remodeling. KEGG topology pointed to enrichment in glycerophospholipid metabolism, taurine and hypotaurine metabolism, and amino acid metabolism. Among the metabolites correlating with better motor performance, one feature tentatively annotated as ganolucidic acid B stood out: it increased with trigonelline treatment, correlated positively with trigonelline-enriched bacterial taxa, and negatively with disease-associated ones. An exploratory network pharmacology analysis of its predicted targets intersected with Parkinson’s genes to yield 146 overlapping targets and ten consensus hub genes, prominently including PIK3CA, PIK3CD, PIK3R1, NFKB1, STAT3, and TNF, with the PI3K-Akt signaling pathway emerging as the most enriched KEGG pathway. The authors are careful to stress that this metabolite’s identity was not confirmed with an authentic standard, and that the network predictions are hypothesis-generating rather than proof of target engagement.

The researchers are equally candid about the study’s broader limits. The AAV-SynA53T model, while faithful to several Parkinson’s-like features, cannot reproduce the chronic, heterogeneous nature of human disease; the signaling changes remain correlative rather than demonstrably causal; and the gut findings reflect system-level associations, leaving open whether trigonelline’s neuroprotection depends on the gut-brain axis or occurs in parallel with direct central effects, particularly since prior work has detected orally administered trigonelline in the brain. Still, the translational arithmetic is tantalizing: the 5 milligram per kilogram mouse dose corresponds to roughly 24.3 milligrams per day for a 60-kilogram adult, a range that overlaps with the trigonelline content of some coffee preparations. That does not mean drinking more coffee will prevent Parkinson’s, since intake varies enormously with bean, roast, and brewing method. But it does mean that a dietary-exposure-range compound has now been shown, in a rigorous multi-omics preclinical framework, to simultaneously quiet neuroinflammation, clear pathological protein, and reshape the gut ecosystem. As the search for disease-modifying Parkinson’s therapies intensifies, trigonelline has earned a place on the shortlist of nutritional neuroprotective candidates worth serious follow-up.

Subject of Research: Neuroprotective and gut microbiome-modulating effects of the coffee alkaloid trigonelline in a mouse model of Parkinson's disease

Article Title: Trigonelline Alleviates Neuroinflammation in AAV‐SynA53T Parkinson's Disease Model Mice: Involvement of PI3K/AKT–NF‐κB Signaling and Gut Microbial‐Metabolic Remodeling

Article References: Chen, M., Dong, Y., Zheng, J., Lin, Y., Li, Q., Wei, C., Zhuo, L., He, Y., Sun, J., Fu, F., & Liu, J. (2026). Trigonelline Alleviates Neuroinflammation in AAV‐SynA53T Parkinson's Disease Model Mice: Involvement of PI3K/AKT–NF‐κB Signaling and Gut Microbial‐Metabolic Remodeling. Food Science & Nutrition, 14(10), Article e72451. https://doi.org/10.1002/fsn3.72451

Image Credits: AI Generated

DOI: 10.1002/fsn3.72451

Keywords: trigonelline, Parkinson's disease, alpha-synuclein, neuroinflammation, gut-brain axis, microglia, PI3K/AKT, NF-kappaB, gut microbiota, Mendelian randomization, metabolomics, coffee

The genus Litophyton, which belongs to the octocoral order Alcyonacea, comprises nearly 100 species distributed across tropical and temperate seas. Colonies can grow up to 80 centimeters tall and appear in pale olive-green, yellow, and grey shades, with a central stalk radiating branches in a characteristic bushy form. Chemically, the genus has earned a reputation as a treasure trove: more than 200 metabolites have been identified from Litophyton species worldwide, including steroids, terpenoids, and meroterpenes, some of which display cytotoxic, antiviral, and antimicrobial properties. Recent work on Litophyton brassicum from the South China Sea described meroterpenes with antibacterial activity against pathogenic strains, while other species have yielded compounds capable of inhibiting HIV protease. Yet the authors note that comprehensive antioxidant evaluation and metabolite profiling of specimens from North Borneo, one of the world’s most biodiverse marine regions, remained conspicuously absent from the literature.

To close that gap, the team obtained collection permits from the Sabah Biodiversity Centre and gathered specimens by scuba diving on July 23 and 24, 2024. Species identity was confirmed molecularly rather than by morphology alone: DNA was extracted from 25 milligrams of homogenized coral tissue, and the 18S ribosomal RNA gene was amplified using the EukA and EukB primer pairs under a standardized polymerase chain reaction protocol. The resulting sequences were compared against the NCBI database to verify that the organism was indeed a member of Litophyton. This molecular confirmation matters in a genus where visual identification can be deceptive and where synonymies, such as the historical merging of Nephthea into Litophyton, have complicated comparisons across older studies.

Back at the Borneo Marine Research Institute, the researchers cleaned the coral of symbiotic animals, cut it to increase surface area, and subjected it to methanol maceration for 72 hours at 27 degrees Celsius with shaking at 120 revolutions per minute, repeating the process with fresh solvent to ensure exhaustive extraction. After rotary evaporation of the combined filtrates, the procedure yielded a crude extract corresponding to 2.82 percent of the starting material. That modest yield is typical for soft coral extraction, but the chemical diversity packed into it proved far more interesting than its mass.

Antioxidant capacity was measured with two complementary radical-scavenging assays. In the DPPH assay, which tracks the bleaching of a stable purple radical at 517 nanometers, the extract showed an IC50 value of 42.63 plus or minus 2.98 milligrams per milliliter, meaning that concentration was needed to neutralize half of the radicals present. The ABTS assay, which generates a green radical cation monitored at 734 nanometers, returned a notably better IC50 of 24.53 plus or minus 2.55 milligrams per milliliter. The authors place these numbers in context: a methanol-dichloromethane extract of the related Nephthea from Sulawesi showed far stronger activity, while an ethyl acetate fraction of the same genus was far weaker. The comparison underscores how extraction solvent, chemical composition, and environment jointly shape the antioxidant signature of these animals.

Quantifying the classical antioxidant compound classes produced a revealing result. Total phenolic content came in at just 0.017 milligrams of gallic acid equivalents per gram, while total flavonoid content reached 0.129 milligrams of quercetin equivalents per gram. Both values are low, which fits the known chemistry of the genus: Litophyton species predominantly manufacture terpenoids, particularly sesquiterpenes, rather than the polyphenols that dominate antioxidant activity in plants. Intriguingly, the flavonoid measurement exceeded the phenolic measurement, and qualitative screening confirmed the presence of both flavonoids and phenolic flavonoids. The researchers argue that the extract’s measurable radical-scavenging capacity cannot be attributed to phenolics alone; alkaloids, steroids, saponins, tannins, and terpenoids, all detected in the qualitative screen, are also recognized contributors to antioxidant potential. Anthraquinones and anthocyanosides, by contrast, were absent.

Fourier-transform infrared spectroscopy added a structural layer to the analysis. The spectrum displayed a broad hydroxyl stretch near 3335 wavenumbers, consistent with alcohols and phenolic compounds; a sharp carbon-hydrogen stretch at 2925 wavenumbers typical of aliphatic hydrocarbons; a peak near 1981 wavenumbers in the triple-bond region, suggestive of alkynes or nitriles though possibly an overtone band; a strong carbonyl signal at 1731 wavenumbers characteristic of aldehydes and ketones; and an alkene-related carbon-carbon double-bond stretch at 1643 wavenumbers. Because the sample was a crude extract rather than a purified compound, the fingerprint region below 1500 wavenumbers was excluded from interpretation, but the functional groups identified align well with a mixture rich in fatty acids, terpenoids, and oxygenated organics.

The centerpiece of the study is the liquid chromatography-quadrupole Orbitrap mass spectrometry profiling, run in both positive and negative ionization modes and analyzed with Compound Discoverer software against the mzCloud and ChemSpider databases. Positive mode revealed 57 metabolites spanning a striking range of chemical classes: fatty acids led at 17 percent, followed by fatty amides at 13 percent and aromatic compounds at 9 percent, with amino acids, terpenoids, and heterocyclic compounds each at 7 percent, and alkaloids and steroids at 6 percent. Negative mode detected 18 metabolites dominated by purines at 29 percent, followed by aromatics at 22 percent and fatty amides at 17 percent. Among the identified molecules were several with well-documented antioxidant credentials: trigonelline, an alkaloid known to scavenge reactive oxygen species and confer neuroprotection in models of Alzheimer’s disease; citral, a monoterpenoid that neutralizes free radicals and modulates antioxidant enzymes; acetyl-L-carnitine, which upregulates glutathione defenses; arachidonic acid, a precursor of redox-regulating eicosanoids; and docosahexaenoic acid, the omega-3 fatty acid that raises intracellular glutathione and exhibits anti-inflammatory effects. Pinolenic acid, creatine, jasmone, and dehydroepiandrosterone also appeared, the latter drawing attention for reported anticancer properties, while negative-mode compounds such as adenine, nipecotic acid, isoleucine, and anatabine carry antioxidant, antimicrobial, and anti-inflammatory resumes of their own.

The authors are careful to frame the findings within their limits. The work relied on crude extracts, in vitro assays, and specimens from a single location and season, so the results cannot yet be generalized across the genus or the region. Still, the implications are considerable. A soft coral once valued mainly for its ornamental appeal emerges as a plausible source of natural antioxidant agents for functional foods, nutraceuticals, and pharmaceuticals, and the researchers point specifically to aquaculture, where such compounds could support disease management and strengthen seafood security. The next steps they propose are the classic progression of marine drug discovery: isolation and characterization of pure metabolites, mechanistic and synergy studies to explain how the observed activity arises from the mixture, standardized extraction protocols to improve yield and reproducibility, and sustainable harvesting or cultivation strategies that protect the reefs that produce these molecules in the first place. For now, the waters of North Borneo have added a new entry to the growing catalogue of marine organisms whose chemistry may one day translate into medicine.

Subject of Research: Antioxidant activity and metabolite profiling of the marine soft coral Litophyton sp. from Sepanggar Island, North Borneo, Malaysia

Article Title: Elucidation of antioxidant activity and metabolite profiling of the marine soft coral Litophyton sp.

Article References: Fauzi, F. A., Yong, Y. S., Tan, J. K., Chong, E. T. J., Ringgit, G., Siddiquee, S., Tayyab, M., Shapawi, R., & Shah, M. D. (2026). Elucidation of antioxidant activity and metabolite profiling of the marine soft coral Litophyton sp.. Blue Biotechnology, 3(1), Article 1. https://doi.org/10.1186/s44315-026-00052-2

Image Credits: AI Generated

DOI: 10.1186/s44315-026-00052-2

Keywords: Litophyton, soft coral, antioxidant, metabolomics, LC-MS, North Borneo, marine natural products, DPPH assay, ABTS assay, fatty acids, trigonelline, bioprospecting